Global Vascular Stent Market Size, Share, Growth Analysis Report - Forecast 2034

Vascular Stent Market: Industry Perspective

The global vascular stent market size was worth around USD 11.48 Billion in 2024 and is predicted to grow to around USD 21.20 Billion by 2034 with a compound annual growth rate (CAGR) of roughly 6.3% between 2025 and 2034. The report analyzes the global vascular stent market's drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the vascular stent industry.

Request Free Sample

Vascular Stent Market: Overview

The vascular stents market is projected to have a bright outlook owing to rising instances of cardiovascular diseases on a global scale. The human lifestyle has drastically changed over the course of the past few years and this has majorly changed the landscape of the vascular stent market.

Increasing instances of heart disorders, a rising geriatric population, increasing research and development in cardiovascular disease treatment, the increasing popularity of minimally invasive surgeries are expected to be prominent factors that govern the vascular stent market growth through 2028. The increasing popularity of minimally invasive surgeries is also expected to positively impact the vascular stent market potential for the given forecast period.

The presence of alternative treatment options and instances of treatment failures are expected to have a hindering effect on the vascular stent market growth.

Key Insights

• As per the analysis shared by our research analyst, the global vascular stent market is estimated to grow annually at a CAGR of around 6.3% over the forecast period (2025-2034).
• Regarding revenue, the global vascular stent market size was valued at around USD 11.48 Billion in 2024 and is projected to reach USD 21.20 Billion by 2034.
• The vascular stent market is projected to grow at a significant rate due to rising incidence of cardiovascular diseases, technological advancements in stent design, and increasing geriatric population.
• Based on Type, the Coronary Stents segment is expected to lead the global market.
• On the basis of Mode of delivery, the Balloon-expandable Stents segment is growing at a high rate and will continue to dominate the global market.
• Based on the End User, the Hospitals & Cardiac Centers segment is projected to swipe the largest market share.
• By Material, the Metallic Stents segment is expected to dominate the global market.
• Based on region, North America is predicted to dominate the global market during the forecast period.

Vascular Stent Market: Growth Drivers

Increasing Prevalence of Cardiovascular Diseases

Instances of cardiovascular diseases have become a widespread phenomenon on a global scale and are majorly influencing vascular stent market growth through 2028. This can be attributed to changing lifestyle habits, rising stress, increasing geriatric population, etc., and these factors subsequently influence vascular stent market growth. Increasing research and development activities to understand these cardiovascular diseases is also expected to result in substantial advancements in the vascular stent marketplace over the forecast period.

Vascular Stent Market: Restraints

Product Failures to Constrain Vascular Stent Growth

The vascular stents market is expected to be majorly restrained by the failure of previously launched medical products. This factor creates suspicion around certain treatment procedures and negatively impacts vascular stent market growth and this is expected to be a major factor that hinders vascular stent market growth potential. Other factors such as the presence of alternative procedures and the long time for product approval by governing bodies also have a hampering effect on the global vascular stent market landscape over the forecast period.

The vascular stent companies are anticipated to invest in better research and development facilities to overcome these restraints and benefit from the complete vascular stent market potential over the forecast period.

Global Vascular Stent Market: Segmentation

The global vascular stent market is segregated based on type, mode of delivery, material, end user, and region.

By type, the market is divided into coronary stents, peripheral stents, carotid stents, renal artery stents, femoral stents, iliac stents, other peripheral stents, EVAR stent grafts, abdominal aortic aneurysm, thoracic aortic aneurysm, bare-metal stents, drug-eluting stents, bioabsorbable stents. The coronary stents segment is expected to continue its dominance over the forecast period and its large market share can be attributed to rising instances of coronary artery disease and rapid technological advancements in the vascular stent marketplace.

On the basis of Mode of delivery, the global vascular stent market is bifurcated into Balloon-expandable Stents, Self-expanding Stents.

By end user, the vascular stent market is segmented into hospitals & cardiac centers, and ambulatory surgical centers. The hospitals & cardiac centers segment holds a major market share in the global vascular stent market landscape and is projected to maintain this stance through 2028. An increasing number of surgeries performed in hospitals are expected to boost vascular stent demand in this segment over the forecast period.

In terms of Material, the global vascular stent market is categorized into Metallic Stents, Cobalt Chromium, Platinum Chromium, Nickel Titanium, Stainless Steel, Other Stents.

Vascular Stent Market: Report Scope

Competitive Landscape

Some of the main competitors dominating the global vascular stent market include - Medtronic, plc (Ireland), Abbott Laboratories (U.S.), Boston Scientific Corporation (U.S.), BIOTRONIK SE & Co. KG (Germany), B. Braun Melsungen AG (Germany), Terumo Corporation (Japan), STENTYS SA (France), MicroPort Scientific Corporation (China), Meril.

Regional Landscape

The market for vascular stents in North America held the largest market share and is anticipated to continue this dominant trend over the forecast period as well. The increasing geriatric population, growing instances of cardiovascular diseases, growing patient pool, increasing adoption of new technologies, and presence of key vascular stent companies are the major factors influencing vascular stent market growth in this region.

Request Free Sample

Low manufacturing costs for the manufacturing of medical devices and increasing medical tourism are two major factors influencing vascular stent market growth in the Asia Pacific region. Emerging economies like India, China, Japan, and Indonesia in this region are expected to provide lucrative opportunities for vascular stent companies throughout the forecast period.

Recent Developments

• In August 2021 – SINOMED a leading name in the medical industry announced the European launch of HT Supreme® Drug-Eluting Stent (DES) and was kicked off with successful implantation at University Hospital Galway in collaboration with National University of Ireland Galway (NUI Galway) by Professor Faisal Sharif.

Vascular Stent Market: Competitive Analysis

The report provides a company market share analysis to give a broader overview of the key market players. In addition, the report also covers key strategic developments of the market, including acquisitions & mergers, new product launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the vascular stent market on a global and regional basis.

The global vascular stent market is dominated by players like:

• Medtronic, plc (Ireland)
• Abbott Laboratories (U.S.)
• Boston Scientific Corporation (U.S.)
• BIOTRONIK SE & Co. KG (Germany)
• B. Braun Melsungen AG (Germany)
• Terumo Corporation (Japan)
• STENTYS SA (France)
• MicroPort Scientific Corporation (China)
• Meril

Global vascular stent market is segmented as follows:

By Type

• Coronary Stents
• Peripheral Stents
• Carotid Stents
• Renal Artery Stents
• Femoral Stents
• Iliac Stents
• Other Peripheral stents
• EVAR Stent Grafts
• Abdominal Aortic Aneurysm
• Thoracic Aortic Aneurysm
• Bare-metal Stents
• Drug-eluting Stents
• Bioabsorbable Stents

By Mode of delivery

• Balloon-expandable Stents
• Self-expanding Stents

By Material

• Metallic Stents
• Cobalt Chromium
• Platinum Chromium
• Nickel Titanium
• Stainless Steel
• Other Stents

By End User

• Hospitals & Cardiac Centers
• Ambulatory Surgical Centers

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France 
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa